The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.
about
Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype.The osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapyAssessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patientsThe immune microenvironment of myelomaThe proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myelomaIdentification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods.Changes in Cytokines of the Bone Microenvironment during Breast Cancer Metastasis.Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone diseaseDepletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells.Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures.Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance.Kinetics of versican-expressing macrophages in bone marrow after cord blood stem cell transplantation for treatment of acute myelogenous leukaemia.The inflammatory chemokine CCL5 and cancer progressionCCR1 as a target for multiple myeloma.Cytotherapies in multiple myeloma: a complementary approach to current treatments?Regulation of cellular processes by interleukin-16 in homeostasis and cancer.Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma.The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?Multiple Myeloma Cells Express Key Immunoregulatory Cytokines and Modulate the Monocyte Migratory Response.Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation.To b(ortezomib) or not to be: the stroma's the thing.Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma.Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20.TNF α mediated IL-6 secretion is regulated by JAK/STAT pathway but not by MEK phosphorylation and AKT phosphorylation in U266 multiple myeloma cells.Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartments.pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune ProfilingIn vivo engineering of bone tissues with hematopoietic functions and mixed chimerism.Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma.Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.
P2860
Q34956540-C6B2220C-A683-4D4A-B33D-B411D09E1C6CQ35145061-BED3E50F-7488-4893-9E88-B81A8108572EQ35466987-DA01DA84-8E78-41B9-A72D-32583F3A5451Q35603152-A2E88FC8-0E3E-4D7F-9E5D-0A9CC2260841Q35648024-E08F129A-7652-425F-9EC4-893B42CB02B7Q35671621-DF8FF356-EE41-42CE-BDF9-F5337FDB870BQ35725996-6FE2621F-538F-44C5-8D49-492B2A3652A7Q35846308-14BEDCF1-0E56-4370-A647-7696EDA534F2Q36177928-EA85DF41-0BFE-4069-A2D1-FDF5B5E8C470Q36493469-912C528D-54CA-4A9E-8AEC-51C647D2A919Q36512406-B188D03C-0D2F-4D3B-B957-8D66D4BA09D7Q37212043-E2D50D8F-4EBF-460E-915B-23CA8AA4B658Q37310229-547239F0-F74C-43DA-B5D4-98070A045CBBQ37541911-B7A943FC-73CF-4439-85B6-86918C384058Q37879210-0682B148-2937-4C0E-809F-2562DB930FECQ38108819-726B9F0C-F780-4026-AFCB-CEE7D984DD1AQ38124813-BFE9949D-FA30-4C49-8C32-1A73B4A355F6Q38155039-5755B847-8831-4F17-A17D-8015171F2B3BQ38239580-5A20DFB9-AC9D-4D84-944E-6C484C915CBEQ38697483-AF19172E-06BD-41AF-8DE6-DC6FBD730045Q38703269-D661C230-E29E-4D2F-BF5D-341654D9B5DDQ38762531-1FEAD7ED-537A-468E-91B5-240610F021D9Q39901834-2D36E0C2-A35F-4CE3-A136-97AF89DEDBB3Q40485837-019C6CD0-70DE-4283-928D-6973EA6111D6Q41760888-78367B40-E4A9-467A-9C3D-5BA9027B32C4Q42158465-8925F851-72F2-48DE-BAF4-DACBC7F17596Q42244787-CDA925C8-802A-465C-89BC-BA12E8FD43BDQ42368100-0BDF22ED-99EB-4C81-BE2E-153868E1AD83Q42373431-31387EEE-3771-45B1-993D-D60C97DC8EDFQ43662865-E1E8CC1C-8373-473C-B922-1F74CB14C64BQ44004521-54952652-BB37-41DF-AD54-B97D1E3C910EQ45756098-F2AA5BE6-D9C4-42C0-8FA8-B8DA2753F213
P2860
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The cytokine/chemokine pattern ...... of multiple myeloma patients.
@en
The cytokine/chemokine pattern ...... of multiple myeloma patients.
@nl
type
label
The cytokine/chemokine pattern ...... of multiple myeloma patients.
@en
The cytokine/chemokine pattern ...... of multiple myeloma patients.
@nl
prefLabel
The cytokine/chemokine pattern ...... of multiple myeloma patients.
@en
The cytokine/chemokine pattern ...... of multiple myeloma patients.
@nl
P2093
P1476
The cytokine/chemokine pattern ...... of multiple myeloma patients.
@en
P2093
Axel R Zander
Carsten Bokemeyer
Djordje Atanackovic
Katrin Bartels
Maja Gordic
Nesrine Lajmi
Nicolaus Kröger
Sabrina Meyer
Sebastian Kobold
Tim Luetkens
P304
P356
10.1016/J.EXPHEM.2010.06.012
P577
2010-07-07T00:00:00Z